why choose us

First received: September 30, 2023

Clinical Trial: Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Subjects

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-Controlled, Single-Centre,Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Brief Summary: The study consists of 6 dose groups, 8 subjects in each group (male or female), randomly assigned to study drug or placebo group to evaluate the safety, tolerability and pharmacokinetics characteristics.

Read more